T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$1.96B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.57B |
| 4 |
GE Aerospace
GE
|
+$1.55B |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$1.43B |
Top Sells
| 1 |
Tesla
TSLA
|
+$2.81B |
| 2 |
Booking.com
BKNG
|
+$2.45B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.8B |
| 4 |
JPMorgan Chase
JPM
|
+$1.31B |
| 5 |
State Street
STT
|
+$1.14B |
Sector Composition
| 1 | Healthcare | 18.46% |
| 2 | Technology | 17.53% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 14.02% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Constellation Brands
STZ
$25.2B
| $112M | 0.02% |
693,436
+136,837
| +25% | +$22M |
|
577
Acadia Pharmaceuticals
ACAD
$4.02B
| $111M | 0.02% |
6,856,137
+3,667,519
| +115% | +$59.3M |
|
578
AutoZone
AZO
$71.1B
| $111M | 0.02% |
131,879
-7,803
| -6% | -$6.54M |
|
579
Capital One
COF
$143B
| $111M | 0.02% |
1,461,976
+36,261
| +3% | +$2.74M |
|
|
EBSB
580
DELISTED
Meridian Bancorp, Inc.
EBSB
| $110M | 0.02% |
7,682,529
+572,097
| +8% | +$8.19M |
|
581
Goldman Sachs
GS
$233B
| $110M | 0.02% |
657,594
+41,076
| +7% | +$6.86M |
|
582
US Physical Therapy
USPH
$1.23B
| $109M | 0.02% |
1,066,303
-53,650
| -5% | -$5.49M |
|
583
Pentair
PNR
$17.9B
| $109M | 0.02% |
2,884,283
-2,096,588
| -42% | -$79.2M |
|
584
Workiva
WK
$4.24B
| $109M | 0.02% |
3,024,266
+1,575,165
| +109% | +$56.5M |
|
585
Agios Pharmaceuticals
AGIO
$2.07B
| $108M | 0.02% |
2,352,730
-477,287
| -17% | -$22M |
|
586
Matsons
MATX
$3.28B
| $108M | 0.02% |
3,378,404
-128,078
| -4% | -$4.1M |
|
587
The Ensign Group
ENSG
$9.59B
| $108M | 0.02% |
2,971,526
+282,630
| +11% | +$10.3M |
|
588
KT
KT
$9.52B
| $108M | 0.02% |
7,559,815
-42,900
| -0.6% | -$610K |
|
|
ARRY
589
DELISTED
Array Biopharma Inc
ARRY
| $107M | 0.02% |
7,527,958
+1,376,845
| +22% | +$19.6M |
|
590
Heritage Financial
HFWA
$842M
| $107M | 0.02% |
3,599,793
+6,759
| +0.2% | +$201K |
|
|
NUVA
591
DELISTED
NuVasive, Inc.
NUVA
| $106M | 0.02% |
2,145,981
-197,532
| -8% | -$9.79M |
|
|
GWR
592
DELISTED
Genesee & Wyoming Inc.
GWR
| $106M | 0.02% |
1,428,949
+35,930
| +3% | +$2.66M |
|
|
BNCL
593
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $106M | 0.02% |
7,390,138
+5,564
| +0.1% | +$79.5K |
|
594
Teva Pharmaceuticals
TEVA
$22.4B
| $106M | 0.02% |
6,844,186
+639,968
| +10% | +$9.87M |
|
595
FibroGen
FGEN
$46.5M
| $105M | 0.02% |
91,092
-2,591
| -3% | -$3M |
|
596
KLA
KLAC
$123B
| $105M | 0.02% |
1,177,599
-7,722,879
| -87% | -$691M |
|
|
STFC
597
DELISTED
State Auto Financial Corp
STFC
| $105M | 0.02% |
3,079,045
-41,465
| -1% | -$1.41M |
|
598
Liberty Latin America Class C
LILAK
$1.54B
| $105M | 0.02% |
7,624,164
+130,625
| +2% | +$1.79M |
|
599
Hubbell
HUBB
$23.5B
| $104M | 0.02% |
1,051,556
-156,848
| -13% | -$15.6M |
|
600
PennyMac Financial
PFSI
$6.22B
| $104M | 0.02% |
4,897,731
+1,018,909
| +26% | +$21.7M |
|